Universidade Nova de Lisboa or NOVA is a Portuguese public university established in 1973, in Lisbon and is the youngest of the three public universities of Lisbon.
NOVA is a higher education institution with internationally recognized research and quality teaching that ensures high levels of professional success to its students.

The following is the list of scholars from Universidade NOVA de Lisboa who currently serve as editors for one or more SciTechnol journals.

• Paulo Gouveia de Almeida, PhD

The following is the list of scholars from Universidade NOVA de Lisboa who published one or more articles in SciTechnol journals.

• Claudio M. Gomes

The following is the list of articles by scholars from Universidade NOVA de Lisboa that are published in SciTechnol journals.

• Antiviral Drug Monitoring: Paving the Path to Precision Medicine in Viral Infections

  Perspective: J Virol Antivir
  DOI:
   Ismail Akhtar
  
  • Full-text
  • PDF
  • Supplementary File

• The Remarkable Rise in Use of Viruses in Potential Medicine

  Perspective: J Virol Antivir
  DOI:
  Sergi Leserno
  
  • Abstract
  • Full-text
  • PDF

• The Dual Role of Antivirals and Vaccines in Treatment and Prevention

  Commentary: J Virol Antivir
  DOI:
  Kyoko Iworimoto
  
  • Abstract
  • Full-text
  • PDF
  • Supplementary File

• Understanding the Complex Anatomy of the H1N1 Influenza Virus

  Short Communication: J Virol Antivir
  DOI:
  Madelon Alauring
  
  • Abstract
  • Full-text
  • PDF
  • Supplementary File

• Monkey Fever: Understanding Kyasanur Forest Disease

  Perspective: J Virol Antivir
  DOI:
  Devendra Univenkappa
  
  • Abstract
  • Full-text
  • PDF

• HIV and the Immune System: A Struggle of Complexity and Resilience

  Opinion Article: J Virol Antivir
  DOI:
  Serena Lellinge
  
  • Abstract
  • Full-text
  • PDF
  • Supplementary File

• A Quiet Pandemic: Crimean-Congo Haemorrhagic Fever

  Perspective: J Virol Antivir
  DOI:
   Vorica Heimann
  
  • Abstract
  • Full-text
  • PDF
  • Supplementary File

• The Role of Viral Shedding in Disease Transmission

  Opinion Article: J Virol Antivir
  DOI:
  Norifumi Suto
  
  • Full-text
  • PDF
  • Supplementary File

• Viral Proteomics: Decoding the Intricate World of Viral Proteins

  Opinion Article: J Virol Antivir
  DOI:
  Stephan Phillips
  
  • Full-text
  • PDF
  • Supplementary File

• RNA Interference (RNAi) Therapies for Rare Genetic Disorders: A Promising Frontier in Precision Medicine

  Commentary: J Virol Antivir
  DOI:
   Lanier Corbin
  
  • Full-text
  • PDF
  • Supplementary File

• Converging Paths: Unraveling the Link between Non-Alcoholic Fatty Liver Disease (NAFLD), Viral Hepatitis, and Potential Therapeutic Synergy

  Perspective: J Virol Antivir
  DOI:
  Esteban Herbert
  
  • Full-text
  • PDF
  • Supplementary File

• Unravelling the Power of Innate Immune Responses to Viral Infections: Safeguarding Our Health from the Outset

  Opinion Article: J Virol Antivir
  DOI:
  Fang Fangchao
  
  • Full-text
  • PDF
  • Supplementary File

• The Intricacies of Host-Virus Interaction: Implications for Health and Disease

  Short Communication: J Virol Antivir
  DOI:
  Arif Alabdallah
  
  • Full-text
  • PDF
  • Supplementary File

• Exploring the Complex Nexus: HIV and the Central Nervous System

  Perspective: J Virol Antivir
  DOI:
  Lacy Schaeffer
  
  • Full-text
  • PDF
  • Supplementary File

• Broad-Spectrum Antivirals: Paving the Way for Pandemic Preparedness

  Opinion Article: J Virol Antivir
  DOI:
  Mathieu Tropsha
  
  • Full-text
  • PDF
  • Supplementary File

• Advancing Antiviral Therapies and Understanding Immune Responses

  Opinion Article: J Virol Antivir
  DOI:
  Chao Wang
  
  • Full-text
  • PDF

• Evaluation of N Gene, S Gene and ORF Based Real-Time RTPCR Assays by Taqpathcovid 19 Combo Kit for Confirmationof SARS-Cov-2 Infection: An Observational Study

  Opinion Article: J Virol Antivir Res 2021, 10: (6)
  DOI:
  Jyoti Khurana*1 , Sulekha Yadav1 , Suman Kumar1 , Anita Mutha2 , Manish Purohit3 , Thang Sunil Ahirwar
  
  • Full-text
  • PDF

• Viral Therapy Advances for Treating Diseases

  Opinion Article: J Virol Antivir Res
  DOI:
  Jong Dejian
  
  • Full-text
  • PDF

• The Potential of Host Defenses: Mechanisms and its Effects

  Opinion Article: J Virol Antivir Res
  DOI:
  Roonei Cooter
  
  • Full-text
  • PDF

• Precise Gene Manipulation Using RNA Interference

  Perspective: J Virol Antivir Res
  DOI:
  Tamang Logan
  
  • Full-text
  • PDF

• Novel Viral Proteomics Techniques and Discoveries

  Short Communication: J Virol Antivir Res
  DOI:
  Olivin Roosar
  
  • Full-text
  • PDF

• Genetic Diversity in Viral Populations

  Perspective: J Virol Antivir Res
  DOI:
  Jang Dinu
  
  • Full-text
  • PDF

• Current Advances and Challenges in Clinical Virology

  Opinion Article: J Virol Antivir Res
  DOI:
  Mercier Bogers
  
  • Full-text
  • PDF

• Advancements in Viral Vector Technology for Gene Therapy

  Opinion Article: J Virol Antivir Res
  DOI:
  Edar Agirre Beitia
  
  • Full-text
  • PDF

• Different Types of Hepatitis their Transmission and Prevention

  Opinion Article: J Virol Antivir Res
  DOI:
  Crabb Hoepelman
  
  • Full-text
  • PDF

• New Frontiers in Anti-Viral Research

  Perspective: J Virol Antivir Res
  DOI:
  Nerea Montagnani
  
  • Full-text
  • PDF

• The Science of Viral Diseases and Their Impact on Health

  Short Communication: J Virol Antivir Res
  DOI:
  Jianguo Hasan
  
  • Full-text
  • PDF

• Entry of Hepatitis B Virus: Innovatory Treatment and their Antiviral Targets

  Opinion Article: J Virol Antivir Res 2021, 10: (6)
  DOI:
  Asahi Ito
  
  • Abstract
  • Full-text
  • PDF

• Viral Proteomics: Worldwide Assessment of Infections and their Interaction

  Commentary: J Virol Antivir Res 2021, 10: (6)
  DOI:
  Qiang Cheung
  
  • Abstract
  • Full-text
  • PDF

• Human Endogenous and Exogenous Retroviruses and clinical Manifestations

  Short Communication: J Virol Antivir Res 2021, 10: (6)
  DOI:
  Adam Cohen
  
  • Abstract
  • Full-text
  • PDF

• Structure and Genome Discovery of HIV Virus and Development of HIV-Protease Inhibitors

  Perspective: J Virol Antivir Res 2021, 10: (6)
  DOI:
  Aegeus Chloros
  
  • Abstract
  • Full-text
  • PDF